Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression

Details 詳細情報について

• CRID

  1362544419415348608

• NII Article ID

  30008181388

• DOI

  10.1016/j.leukres.2003.11.018

• ISSN

  01452126

• Web Site

  https://api.elsevier.com/content/article/PII:S014521260300417X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S014521260300417X?httpAccept=text/plain

• Data Source

  • Crossref
  • CiNii Articles